Deep search
Rewards
Search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Trending on Bing
Says he is 'firmly committed'
Bloomberg donates $1B
Quits over Biden's interview
'General Hospital' actor dies
Ruling in 'Rust' hearing
No Parkinson's treatments
Tire flies off during takeoff
RNC's new abortion stance
13 missing hikers found
$1,000 for new parents?
Invests millions in Smartmatic
Columbia removes 3 deans
NASCAR launches probe
Napoleon’s pistols sold
Pleads guilty in Jan. 6 attack
Neverland Ranch threatened
Millions without power
Higher education survey
New fertility pill sparks hope
Vegas breaks heat record
Cape Town homes destroyed
‘Rotten egg’ atmosphere
Over 1,300 flights canceled
VP pick likely this week
Housing slump deepened
Violent holiday weekend
Beryl downgraded
Olympic roster announced
Hit record highs
New bird flu study
Military land deals review
Inspections over mask issue
TSA sets screening record
Fritz reaches quarterfinals
$50M deal with UConn
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Diabetes, Ozempic and Cancer Risks
What to know about new study showing weight loss drugs can lower cancer risk
Clinical studies show users of the medications can lose between 5% and 20% of their body weight over time. The study authors wrote that more research is needed to determine exactly how and why GLP-1 drugs may contribute to a lower risk of obesity-associated cancers.
Ozempic and Related Drugs May Reduce Cancer Risks, Study Claims
GLP-1 drugs like Ozempic may lower obesity-related cancer risks, although no direct correlation has been confirmed.
Popular weight-loss and diabetes medications linked to lower risk of some cancers, study finds
GLP-1 medications such as Ozempic and Wegovy may help lower the risk of certain cancers, a new study suggests.
Healthline
3d
GLP-1 Drugs Like Ozempic May Reduce Risk of These 10 Cancers
Share on Pinterest A study finds that people with type 2 diabetes who took semaglutide were less likely to develop certain ...
The American Journal of Managed Care
3d
GLP-1 Agonists May Reduce Cancer Risk for Patients With Diabetes
Among patients with type 2 diabetes, glucagon-like peptide 1 (GLP-1) receptor agonists reduced their risk of obesity-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ozempic
Wegovy
Feedback